168 related articles for article (PubMed ID: 22253809)
1. CD1 gene polymorphisms and phenotypic variability in X-linked adrenoleukodystrophy.
Barbier M; Sabbagh A; Kasper E; Asheuer M; Ahouansou O; Pribill I; Forss-Petter S; Vidaud M; Berger J; Aubourg P
PLoS One; 2012; 7(1):e29872. PubMed ID: 22253809
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel SNPs of ABCD1, ABCD2, ABCD3, and ABCD4 genes in patients with X-linked adrenoleukodystrophy (ALD) based on comprehensive resequencing and association studies with ALD phenotypes.
Matsukawa T; Asheuer M; Takahashi Y; Goto J; Suzuki Y; Shimozawa N; Takano H; Onodera O; Nishizawa M; Aubourg P; Tsuji S
Neurogenetics; 2011 Feb; 12(1):41-50. PubMed ID: 20661612
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants of methionine metabolism and X-ALD phenotype generation: results of a new study sample.
Semmler A; Bao X; Cao G; Köhler W; Weller M; Aubourg P; Linnebank M
J Neurol; 2009 Aug; 256(8):1277-80. PubMed ID: 19353223
[TBL] [Abstract][Full Text] [Related]
4. Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients.
Jang J; Kang HC; Kim HS; Kim JY; Huh YJ; Kim DS; Yoo JE; Lee JA; Lim B; Lee J; Yoon TM; Park IH; Hwang DY; Daley GQ; Kim DW
Ann Neurol; 2011 Sep; 70(3):402-9. PubMed ID: 21721033
[TBL] [Abstract][Full Text] [Related]
5. Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in The Netherlands: a survey of 30 kindreds.
van Geel BM; Assies J; Weverling GJ; Barth PG
Neurology; 1994 Dec; 44(12):2343-6. PubMed ID: 7991123
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy.
Asheuer M; Bieche I; Laurendeau I; Moser A; Hainque B; Vidaud M; Aubourg P
Hum Mol Genet; 2005 May; 14(10):1293-303. PubMed ID: 15800013
[TBL] [Abstract][Full Text] [Related]
7. [X-linked adrenoleukodystrophy].
Aubourg P
Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287
[TBL] [Abstract][Full Text] [Related]
8. ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations.
Kemp S; Pujol A; Waterham HR; van Geel BM; Boehm CD; Raymond GV; Cutting GR; Wanders RJ; Moser HW
Hum Mutat; 2001 Dec; 18(6):499-515. PubMed ID: 11748843
[TBL] [Abstract][Full Text] [Related]
9. Integrative lipidomic and transcriptomic analysis of X-linked adrenoleukodystrophy reveals distinct lipidome signatures between adrenomyeloneuropathy and childhood cerebral adrenoleukodystrophy.
Lee DK; Long NP; Jung J; Kim TJ; Na E; Kang YP; Kwon SW; Jang J
Biochem Biophys Res Commun; 2019 Jan; 508(2):563-569. PubMed ID: 30509496
[TBL] [Abstract][Full Text] [Related]
10. X-linked adrenoleukodystrophy in a chimpanzee due to an ABCD1 mutation reported in multiple unrelated humans.
Curiel J; Steinberg SJ; Bright S; Snowden A; Moser AB; Eichler F; Dubbs HA; Hacia JG; Ely JJ; Bezner J; Gean A; Vanderver A
Mol Genet Metab; 2017 Nov; 122(3):130-133. PubMed ID: 28919002
[TBL] [Abstract][Full Text] [Related]
11. X-linked adrenoleukodystrophy phenotype is independent of ABCD2 genotype.
Maier EM; Mayerhofer PU; Asheuer M; Köhler W; Rothe M; Muntau AC; Roscher AA; Holzinger A; Aubourg P; Berger J
Biochem Biophys Res Commun; 2008 Dec; 377(1):176-80. PubMed ID: 18834860
[TBL] [Abstract][Full Text] [Related]
12. Retrospective evaluation of patients with X-linked adrenoleukodystrophy with a wide range of clinical presentations: a single center experience.
Olgac A; Kasapkara ÇS; Derinkuyu B; Yüksel D; Çetinkaya S; Aksoy A; Ceylaner S; Güleray N; Yeşilipek A; Aydın Hİ; Orgun LT; Kılıç M
J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1169-1179. PubMed ID: 34162029
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis and genotype-phenotype correlation of 29 unrelated Japanese patients with X-linked adrenoleukodystrophy.
Takano H; Koike R; Onodera O; Sasaki R; Tsuji S
Arch Neurol; 1999 Mar; 56(3):295-300. PubMed ID: 10190819
[TBL] [Abstract][Full Text] [Related]
14. Therapy of X-linked adrenoleukodystrophy.
Semmler A; Köhler W; Jung HH; Weller M; Linnebank M
Expert Rev Neurother; 2008 Sep; 8(9):1367-79. PubMed ID: 18759549
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of human CD1a, CD1d, and CD1e in exon 2 in Chinese Han and She ethnic populations.
Gan LH; Pan YQ; Xu DP; Li M; Lin A; Yan WH
Tissue Antigens; 2010 Jun; 75(6):691-5. PubMed ID: 20136774
[TBL] [Abstract][Full Text] [Related]
16. General aspects and neuropathology of X-linked adrenoleukodystrophy.
Ferrer I; Aubourg P; Pujol A
Brain Pathol; 2010 Jul; 20(4):817-30. PubMed ID: 20626743
[TBL] [Abstract][Full Text] [Related]
17. CD1A, D and E gene polymorphisms in a North African population from Morocco.
Aureli A; Oumhani K; Del Beato T; El Aouad R; Piancatelli D
Hum Immunol; 2016 Jul; 77(7):566-70. PubMed ID: 27156638
[TBL] [Abstract][Full Text] [Related]
18. Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy.
Pujol A; Hindelang C; Callizot N; Bartsch U; Schachner M; Mandel JL
Hum Mol Genet; 2002 Mar; 11(5):499-505. PubMed ID: 11875044
[TBL] [Abstract][Full Text] [Related]
19. The cystathionine beta-synthase variant c.844_845ins68 protects against CNS demyelination in X-linked adrenoleukodystrophy.
Linnebank M; Semmler A; Kleijer WJ; van der Sterre ML; Gärtner J; Fliessbach K; Sokolowski P; Köhler W; Schlegel U; Klockgether T; Wanders RJ; Schmidt S; Wüllner U; Kemp S
Hum Mutat; 2006 Oct; 27(10):1063-4. PubMed ID: 16941496
[TBL] [Abstract][Full Text] [Related]
20. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
Singh J; Olle B; Suhail H; Felicella MM; Giri S
J Neurochem; 2016 Jul; 138(1):86-100. PubMed ID: 26849413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
